Eli Lilly

Medicare Won't Pay For Eli Lilly Alzheimer's Agent Eli Lilly & Co. says it will push ahead with a first-of-a-kind imaging chemical designed to help screen for Alzheimer's disease, despite a negative ruling by Medicare officials.
Alzheimer's Drug Fails Study But Flashes Potential An Alzheimer's treatment from Eli Lilly and Co. failed to slow memory decline in two separate patient studies, but the drug did show some potential to help in mild cases of the mind-robbing condition that is notoriously difficult to treat.
The Taz Show

Listen Live